PTC Therapeutics, Inc. (PTCT) Return on equity 2016–2021
PTC Therapeutics, Inc. (PTCT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-36432.6%FY2021 · since FY2016: -118.8% → -36432.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -36432.6% | -36341.7 pp |
| FY2020 | -90.9% | -48.6 pp |
| FY2019 | -42.3% | -5.8 pp |
| FY2018 | -36.5% | +14.0 pp |
| FY2017 | -50.5% | +68.3 pp |
| FY2016 | -118.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice